Solution Temperature for Hysteroscopic Surgery
(STOFD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how the temperature of a saline solution used during hysteroscopic surgery (a procedure to treat conditions inside the uterus) impacts fluid absorption. The goal is to determine if the solution's temperature affects the risk of fluid overload, a complication that can cause issues like bleeding. The trial will test saline at three different temperatures: cold, room temperature, and body temperature. Women undergoing hysteroscopic surgery, who are not using certain alternative solutions, might be suitable candidates. As an unphased trial, this study offers participants the chance to contribute to important research that could enhance surgical safety and outcomes.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that this method is safe for hysteroscopic surgery?
Research has shown that using 0.9% saline during hysteroscopic surgery is generally safe, with a low complication rate of about 0.22%. Possible risks include a tear in the uterus, heavy bleeding, and excessive fluid absorption. Excessive fluid absorption can occur if the body takes in too much of the liquid used during the procedure. However, no cases of OHIA syndrome have been reported with saline use.
Using warm saline at 37 degrees Celsius can reduce pain compared to room temperature saline. Both warm and room temperature saline have been used without serious problems. Still, there is a risk of excessive fluid absorption if the surgery takes too long or uses too much liquid. Overall, 0.9% saline at these temperatures appears to be well-tolerated.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how the temperature of saline solutions used in hysteroscopic surgery might impact outcomes. Unlike current practices that don't typically consider temperature variations, this trial investigates saline solutions at three different temperatures: cooled to 17 degrees Celsius, warmed to 24 degrees Celsius, and further warmed to 37 degrees Celsius. By doing so, the trial aims to discover if altering the temperature could enhance surgical precision, reduce discomfort, or improve recovery times. This could lead to a more tailored approach in hysteroscopic procedures, potentially offering more comfort and better results for patients.
What evidence suggests that this trial's treatments could be effective for reducing fluid overload in hysteroscopic surgery?
This trial will compare the effects of different saline temperatures during hysteroscopic surgery. Research has shown that warmed saline can reduce pain more effectively than room-temperature saline. Participants may receive 0.9% saline warmed to either 37 degrees Celsius or 24 degrees Celsius. Warm fluids generally provide more comfort, aiding in pain management. Studies have found both 37°C (body temperature) and 24°C saline effective, but more evidence supports warmer fluids for comfort. However, fluid overload, which occurs when the body absorbs too much fluid, poses a risk. Monitoring fluid absorption during surgery is crucial to avoid complications. Overall, using warmer saline appears promising for pain reduction, but safety measures are essential to prevent fluid-related issues.12345
Who Is on the Research Team?
Aya Mohr-Sasson
Principal Investigator
The University of Texas Health Science Center, Houston, TX
Are You a Good Fit for This Trial?
This trial is for women undergoing hysteroscopic surgery, a procedure used to treat various gynecological issues. It's open to all women who are scheduled for this type of surgery.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo hysteroscopic surgery with randomly assigned irrigation fluid temperatures
Immediate Post-operative Monitoring
Participants are monitored for immediate post-surgical pain and fluid deficit
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- 0.9% Saline cooled to 17 degrees Celsius
- 0.9% Saline warmed to 24 degrees Celsius
- 0.9% Saline warmed to 37 degrees Celsius
- Hysteroscopic surgery
0.9% Saline cooled to 17 degrees Celsius is already approved in European Union, United States, Canada for the following indications:
- General medical use as a diluent or vehicle for intravenous administration
- Hysteroscopic procedures
- General medical use as a diluent or vehicle for intravenous administration
- Hysteroscopic procedures
- General medical use as a diluent or vehicle for intravenous administration
- Hysteroscopic procedures
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor